Last reviewed · How we verify
Bioequivalence of Two Fluticasone Propionate 0.05% Topical Creams
The purpose of this study was to compare the relative vasoconstrictive effects of test and reference topical Fluticasone Propionate 0.05% Cream in healthy, female subjects.
Details
| Lead sponsor | Padagis LLC |
|---|---|
| Status | COMPLETED |
| Enrolment | 115 |
| Start date | 2003-04 |
| Completion | 2003-06 |
Conditions
- Healthy
Interventions
- Fluticasone Propionate 0.05% Cream-Reference Product
- Fluticasone Propionate 0.05% Cream-Test product
Primary outcomes
- Vasoconstriction will be measured by the degree of skin blanching observed after treatment removal using a ChromaMeter — Over the course of two days